Towards the Lowest Efficacious Dose: Results From a Multicenter Noninferiority Randomized Open ‐Label Controlled Trial Assessing Tocilizumab or Abatacept Injection Spacing in Rheumatoid Arthritis in Remission

ConclusionThe Towards the Lowest Efficacious Dose trial failed to demonstrate NI for the proposed ABA or TCZ tapering strategy.

Source: Arthritis and Rheumatology - January 26, 2024 Category: Rheumatology Authors: Joanna Kedra, Philippe Dieud é, Caroline Giboin, Hubert Marotte, Carine Salliot, Thierry Schaeverbeke, Aleth Perdriger, Martin Soubrier, Jacques Morel, Arnaud Constantin, Emmanuelle Dernis, Valérie Royant, Jean‐Hugues Salmon, Thao Pham, Tags: Full Length Source Type: research